VPIM
PYXS icon

Vanguard Personalized Indexing Management’s Pyxis Oncology PYXS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,987
Closed -$12.7K – 2020
2025
Q1 		$12.7K Buy
+12,987
New +$17.3K ﹤0.01% 1817

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Personalized Indexing Management's PYXS Position: Q2 2025 in Review

Vanguard Personalized Indexing Management sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 12,987 shares — an estimated $12.7K sold.

Vanguard Personalized Indexing Management first reported a position in PYXS in Q1 2025 and held it in 1 quarter. The position peaked at $12.7K in Q1 2025. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

  • Vanguard Personalized Indexing Management reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 12,987 Pyxis Oncology shares in Q2 2025, an estimated $12.7K.
  • Vanguard Personalized Indexing Management first reported a position in Pyxis Oncology in Q1 2025 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Pyxis Oncology position peaked at $12.7K in Q1 2025.
  • 74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2025, filed 25 Jul 2025.